Literature DB >> 221453

Use of recombinant plasmids to characterize collagen RNAs in normal and transformed chick embryo fibroblasts.

S L Adams, J C Alwine, B de Crombrugghe, I Pastan.   

Abstract

Two recombinant plasmids containing chick collagen DNA sequences have been used to characterize messenger RNAs for pro-alpha1 (type I) and pro-alpha2 collagen. Poly(A)-containing RNA from chick embryo calvaria and long bones, tissues which are very active in collagen synthesis, were electrophoresed on agarose gels containing methylmercuric hydroxide and transferred to diazobenzyloxymethyl paper; these covalently bound RNAs were hybridized to 32P-labeled pro-alpha1 or pro-alpha2 collagen DNA sequences derived from the recombinant plasmids. The pro-alpha1 collagen probe identified two RNAs, a major species of 5000 bases and a minor species of 7100 bases; the pro-alpha2 collagen probe hybridized to a major species very similar in size to the pro-alpha1 mRNA, about 5200 bases, and a minor species of 5700 bases. It is possible that the 7100 and 5700 base RNAs represent precursors of pro-alpha1 and pro-alpha2 collagen mRNA, respectively. When similar hybridization experiments were performed with RNA from chick embryo fibroblasts, both the pro-alpha1 and pro-alpha2 collagen mRNAs were observed, as well as their corresponding larger species. With RNAs from fibroblasts transformed by Rous sarcoma virus, however, the levels of all RNA species which hybridized with the pro-alpha1 and pro-alpha2 collagen DNA probes were significantly reduced.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 221453

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

Review 1.  Molecular mechanisms of collagen gene expression.

Authors:  R Raghow; J P Thompson
Journal:  Mol Cell Biochem       Date:  1989-03-16       Impact factor: 3.396

2.  Expression of type X collagen is transiently stimulated in redifferentiating chondrocytes pretreated with retinoic acid.

Authors:  M Sanchez; E Gionti; G Pontarelli; A Arcella; F De Lorenzo
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

3.  Inhibition of epidermal growth factor receptor biosynthesis caused by the src oncogene product, pp60v-src.

Authors:  W J Wasilenko; M Nori; N Testerman; M J Weber
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

4.  Down regulation by p60v-src of genes specifically expressed and developmentally regulated in postmitotic quail neuroretina cells.

Authors:  M Guermah; G Gillet; D Michel; D Laugier; G Brun; G Calothy
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

5.  Suppression of v-src transformation by the drs gene.

Authors:  H Inoue; J Pan; A Hakura
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

6.  Control of types I and II collagen and fibronectin gene expression in chondrocytes delineated by viral transformation.

Authors:  E S Allebach; D Boettiger; M Pacifici; S L Adams
Journal:  Mol Cell Biol       Date:  1985-05       Impact factor: 4.272

7.  Insertion of retrovirus into the first intron of alpha 1(I) collagen gene to embryonic lethal mutation in mice.

Authors:  K Harbers; M Kuehn; H Delius; R Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

8.  Loss of type I procollagen gene expression in SV40-transformed human fibroblasts is accompanied by hypermethylation of these genes.

Authors:  M I Parker; K Judge; W Gevers
Journal:  Nucleic Acids Res       Date:  1982-10-11       Impact factor: 16.971

9.  Simian virus 40-associated small RNA: mapping on the simian virus 40 genome and characterization of its synthesis.

Authors:  J C Alwine; G Khoury
Journal:  J Virol       Date:  1980-12       Impact factor: 5.103

10.  Molecular mechanism for the capture and excision of the transforming gene of avian sarcoma virus as suggested by analysis of recombinant clones.

Authors:  T Yamamoto; J S Tyagi; J B Fagan; G Jay; B deCrombrugghe; I Pastan
Journal:  J Virol       Date:  1980-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.